Cardiotoxicity Associated with Anti-CD19 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy: Recognition, Risk Factors, and Management

被引：32

作者：

Burns, Ethan A. ^{[1
]}

Gentille, Cesar ^{[1
]}

Trachtenberg, Barry ^{[2
]}

Pingali, Sai Ravi ^{[1
]}

Anand, Kartik ^{[3
]}

机构：

[1] Houston Methodist Hosp, Houston Methodist Canc Ctr, Outpatient Ctr, 6445 Main St,24th Floor, Houston, TX 77030 USA

[2] Houston Methodist DeBakey Heart & Vasc Ctr, 6565 Fannin St, Houston, TX 77030 USA

[3] Great Plains Hlth, Callahan Canc Ctr, 601 W Leota St, North Platte, NE 69101 USA

来源：

DISEASES | 2021年 / 9卷 / 01期

关键词：

CAR-T; cardiotoxicity; hypotension; heart failure; cytokine release syndrome; leukemia; lymphoma; CYTOKINE RELEASE SYNDROME; INTERLEUKIN-6; DIAGNOSIS; MYELOMA; ADULTS;

D O I：

10.3390/diseases9010020

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Chimeric antigen receptor T-cells (CAR-T) are improving outcomes in pediatric and adult patients with relapsed or refractory B-cell acute lymphoblastic leukemias and subtypes of non-Hodgkin Lymphoma. As this treatment is being increasingly utilized, a better understanding of the unique toxicities associated with this therapy is warranted. While there is growing knowledge on the diagnosis and treatment of cytokine release syndrome (CRS), relatively little is known about the associated cardiac events that occur with CRS that may result in prolonged length of hospital stay, admission to the intensive care unit for pressor support, or cardiac death. This review focuses on the various manifestations of cardiotoxicity, potential risk factors, real world and clinical trial data on prevalence of reported cardiotoxicity events, and treatment recommendations.

引用

页数：15

共 52 条

[1] Cytokine Release Syndrome With the Novel Treatments of Acute Lymphoblastic Leukemia: Pathophysiology, Prevention, and Treatment [J].

Aldoss, Ibrahim ;

Khaled, Samer K. ;

Budde, Elizabeth ;

Stein, Anthony S. .

CURRENT ONCOLOGY REPORTS, 2019, 21 (01)

[2] Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T) [J].

Alvi, Raza M. ;

Frigault, Matthew J. ;

Fradley, Michael G. ;

Jain, Michael D. ;

Mahmood, Syed S. ;

Awadalla, Magid ;

Lee, Dae Hyun ;

Zlotoff, Daniel A. ;

Zhang, Lili ;

Drobni, Zsofia D. ;

Hassan, Malek Z. O. ;

Bassily, Emmanuel ;

Rhea, Isaac ;

Ismail-Khan, Roohi ;

Mulligan, Connor P. ;

Banerji, Dahlia ;

Lazaryan, Aleksandr ;

Shah, Bijal D. ;

Rokicki, Adam ;

Raje, Noopur ;

Chavez, Julio C. ;

Abramson, Jeremy ;

Locke, Frederick L. ;

Neilan, Tomas G. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (25) :3099-3108

[3] Diagnosis of adrenal insufficiency in severe sepsis and septic shock [J].

Annane, Djillali ;

Maxime, Virginie ;

Ibrahim, Fidaa ;

Alvarez, Jean Claude ;

Abe, Emuri ;

Boudou, Philippe .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (12) :1319-1326

[4] Cardiotoxicity of Immunotherapy: Incidence, Diagnosis, and Management [J].

Asnani, Aarti .

CURRENT ONCOLOGY REPORTS, 2018, 20 (06)

[5] Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation [J].

Bethin, KE ;

Vogt, SK ;

Muglia, LJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9317-9322

[6] Interleukin-1 blockade in cardiovascular diseases: a clinical update [J].

Buckley, Leo F. ;

Abbate, Antonio .

EUROPEAN HEART JOURNAL, 2018, 39 (22) :2063-+

[7] Cardiac Profile of Chimeric Antigen Receptor T Cell Therapy in Children: A Single-Institution Experience [J].

Burstein, Danielle S. ;

Maude, Shannon ;

Grupp, Stephen ;

Griffis, Heather ;

Rossano, Joseph ;

Lin, Kimberly .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (08) :1590-1595

[8] Cardiotoxicity of Contemporary Anticancer Immunotherapy [J].

Dalbo, Natalie ;

Patel, Rushin ;

Parikh, Rohan ;

Shah, Sachin P. ;

Guha, Avirup ;

Dani, Sourbha S. ;

Ganatra, Sarju .

CURRENT TREATMENT OPTIONS IN CARDIOVASCULAR MEDICINE, 2020, 22 (12)

[9] Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia [J].

Davila, Marco L. ;

Riviere, Isabelle ;

Wang, Xiuyan ;

Bartido, Shirley ;

Park, Jae ;

Curran, Kevin ;

Chung, Stephen S. ;

Stefanski, Jolanta ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Fink, Mitsu ;

Shinglot, Himaly ;

Youssif, Maher ;

Satter, Mark ;

Wang, Yongzeng ;

Hosey, James ;

Quintanilla, Hilda ;

Halton, Elizabeth ;

Bernal, Yvette ;

Bouhassira, Diana C. G. ;

Arcila, Maria E. ;

Gonen, Mithat ;

Roboz, Gail J. ;

Maslak, Peter ;

Douer, Dan ;

Frattini, Mark G. ;

Giralt, Sergio ;

Sadelain, Michel ;

Brentjens, Renier .

SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (224)

[10] Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008 [J].

Dellinger, R. Phillip ;

Levy, Mitchell M. ;

Carlet, Jean M. ;

Bion, Julian ;

Parker, Margaret M. ;

Jaeschke, Roman ;

Reinhart, Konrad ;

Angus, Derek C. ;

Brun-Buisson, Christian ;

Beale, Richard ;

Calandra, Thierty ;

Dhainaut, Jean-Francois ;

Gerlach, Herwig ;

Harvey, Maurene ;

Marini, John J. ;

Marshall, John ;

Ranieri, Marco ;

Ramsay, Graham ;

Sevransky, Jonathan ;

Thompson, B. Taylor ;

Townsend, Sean ;

Vender, Jeffrey S. ;

Zimmerman, Janice L. ;

Vincent, Jean-Louis .

CRITICAL CARE MEDICINE, 2008, 36 (01) :296-327

← 1 2 3 4 5 6 →